Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has been ...

In another departure from its core focus on genetic medicines, Vertex Pharma has agreed a $4.9 billion purchase of Alpine Immune Sciences, adding a mid-stage drug candidate for kidney disease IgA ...

It's a good idea to go against the current market sentiment on this one. Vertex Pharmaceuticals continues to generate most of its revenue from its cystic fibrosis (CF) franchise. The company's ...

We may receive a commission on purchases made from links. There are multiple benefits to owning an electric snow shovel, including how it's a happy medium between expensive snow blowers and manual ...

It's your last chance to score major savings on the most popular brands before Amazon's Cyber Monday sale ends tonight.

Black Friday is over, and Cyber Monday deals officially kick off tomorrow, but you don't have to wait until Dec. 1 to access ...

News headlines Vertex Pharmaceuticals (VRTX) is experiencing notable momentum with revised analyst estimates and a focus on its expanding pipeline. Recent performance has shown a 9.2% increase over ...

Amazon Canada's Black Friday sale is in full swing and it includes some of the retailer's best — and steepest — deals of the ...

🛍️ The best Cyber Monday deals you can shop right now (updating) 🛍️ By Stan Horaczek Published Nov 20, 2025 12:11 PM EST We may earn revenue from the products available on this page and participate ...

News headlines Vertex Pharmaceuticals (VRTX) is gaining traction among investors, buoyed by promising clinical data and potential regulatory advancements. Recent market sentiment also improved due to ...